Your browser doesn't support javascript.
loading
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study.
Lucini, Chantal; Obrová, Klára; Krickl, Isabella; Nogueira, Filomena; Kocmanová, Iva; Herndlhofer, Susanne; Gleixner, Karoline V; Sperr, Wolfgang R; Frank, Tijana; Andrade, Nuno; Peters, Christina; Engstler, Gernot; Dworzak, Michael; Attarbaschi, Andishe; van Grotel, Martine; van den Heuvel-Eibrink, Marry M; Moiseev, Ivan S; Rogacheva, Yuliya; Zubarovskaya, Ludmilla; Zubarovskaya, Natalia; Pichler, Herbert; Lawitschka, Anita; Koller, Elisabeth; Keil, Felix; Mayer, Jirí; Weinbergerová, Barbora; Valent, Peter; Lion, Thomas.
Afiliación
  • Lucini C; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Obrová K; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Krickl I; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Nogueira F; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Kocmanová I; Department of Clinical Microbiology and Immunology, University Hospital Brno, Brno, Czech Republic.
  • Herndlhofer S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Gleixner KV; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Sperr WR; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Frank T; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Andrade N; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Peters C; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Engstler G; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Dworzak M; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Attarbaschi A; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • van Grotel M; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • van den Heuvel-Eibrink MM; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Moiseev IS; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Rogacheva Y; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
  • Zubarovskaya L; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Zubarovskaya N; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Pichler H; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Lawitschka A; Division of Childhealth, Wilhelmina Childrens Hospital, University of Utrecht, Utrecht, the Netherlands.
  • Koller E; RM Gorbacheva Children Research Institute, Pavlov University, Saint Petersburg, Russian Federation.
  • Keil F; RM Gorbacheva Children Research Institute, Pavlov University, Saint Petersburg, Russian Federation.
  • Mayer J; RM Gorbacheva Children Research Institute, Pavlov University, Saint Petersburg, Russian Federation.
  • Weinbergerová B; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Valent P; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Lion T; St. Anna Children's Cancer Research Institute (CCRI), Zimmermannplatz 10, Vienna, A-1090, Austria.
J Hematol Oncol ; 17(1): 63, 2024 08 07.
Article en En | MEDLINE | ID: mdl-39113112
ABSTRACT
Invasive fungal disease (IFD) presents a life-threatening condition in immunocompromised patients, thus often prompting empirical administration of antifungal treatment, without adequate mycological evidence. Over the past years, wide use of antifungal prophylaxis resulted in decreased occurrence of IFD but has contributed to changes in the spectrum of fungal pathogens, revealing the occurrence of previously rare fungal genera causing breakthrough infections. The expanding spectrum of clinically relevant fungal pathogens required the implementation of screening approaches permitting broad rather than targeted fungus detection to support timely onset of pre-emptive antifungal treatment. To address this diagnostically important aspect in a prospective setting, we analyzed 935 serial peripheral blood (PB) samples from 195 pediatric and adult patients at high risk for IFD, involving individuals displaying febrile neutropenia during treatment of hematological malignancies or following allogeneic hematopoietic stem cell transplantation. Two different panfungal-PCR-screening methods combined with ensuing fungal genus identification by Sanger sequencing were employed. In the great majority of PB-specimens displaying fungal DNAemia, the findings were transient and revealed fungi commonly regarded as non-pathogenic or rarely pathogenic even in the highly immunocompromised patient setting. Hence, to adequately exploit the diagnostic potential of panfungal-PCR approaches for detecting IFD, particularly if caused by hitherto rarely observed fungal pathogens, it is necessary to confirm the findings by repeated testing and to identify the fungal genus present by ensuing analysis. If applied appropriately, panfungal-PCR-screening can help prevent unnecessary empirical therapy, and conversely, contribute to timely employment of effective pre-emptive antifungal treatment strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN de Hongos / Huésped Inmunocomprometido / Neutropenia Febril Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN de Hongos / Huésped Inmunocomprometido / Neutropenia Febril Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article